Eargo

Ticker: EAR

Sector: Medical Devices

Eargo

Eargo is known for being one of the smallest OTC hearing aids on the market. The Eargo 7 is the newest model with Sound Adjust+ with Clarity Mode, which makes automatic sound adjustments as you move between environments for a clearer listening experience. Eargo SE Self-Fitting OTC Hearing Aids are FDA-Cleared medical devices and Eargos latest virtually invisible CIC devices, made with performance and value. Eargo stock forecast for the beginning of next year is $ 4.76. The Eargo Stock prediction for 2025 is currently $’4.77. Eargos price history shows that Eargo has performed -88.61% worse in the last year. Traders use a variety of tools to make a prediction on which way the EAR market is likely to head next. Traders also use the RSI and Fibonacci retracement level indicators to try and ascertain the future direction. The most affordable hearing aids on the market include Audien, Lexie, Eargo, Jabra Enhance, MDHearing, Audicus, Audica, and Signia. Eargo is virtually invisible, rechargeable, completely in-the-canal devices. Eargo has long been known as the Apple of hearing aids. Eargo 5 hearing aids are practically invisible when worn. Lexie B2 hearing aids (powered by Bose) are designed to provide superior sound quality, convenience, comfort to those with hearing loss.